Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.
Latest SPAC News: Vertex set to be first SPAC to list in Singapore; Delaware Chancery Court opens door to liability for SPACs
Temasek-Backed Vertex Set to Be First SPAC to List in Singapore
Delaware Chancery Court Opens Door to Liability for SPAC Sponsors
Delaware’s Chancery Court has just put special purpose acquisition company insiders on notice: If they don’t tell the whole truth about proposed deals, they may be on the hook to investors.
Vice Chancellor Lori Will ruled Tuesday in In re MultiPlan Corp Stockholders Litigation that investors in the Churchill Capital Corp III SPAC can move forward with claims that the SPAC’s insiders, including former Citigroup Inc executive Michael Klein, breached their fiduciary duties by failing to disclose critical information about the SPAC’s target, the healthcare cost management company MultiPlan Corp.
READ
AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...
At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...